Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH)

Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
18. 80
-1.8
-8.7379%
$
671.02M Market Cap
- P/E Ratio
- Div Yield
595,900 Volume
- Eps
$ 20.6
Previous Close
Investors:
Add Transaction
Day Range
18.29 21
Year Range
7.45 42.14
Want to track FTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Faeth Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
John H. Burbank III
John H. Burbank III Passport Capital LLC
1.29M $32.16M $26.9M -$5.26M -16.36%
Li Peng
Li Peng China Universal Asset Management Co. Ltd.
3,600 $86,400 $66,763.8 -$19,636.2 -22.73%
George Song
George Song Superstring Capital Management LP
14,175 $354,375 $266,258.95 -$88,116.05 -24.87%
Drew Phillips
Drew Phillips Fortitude Family Office LLC
17 $506 $350.2 -$155.8 -30.79%
Olga Maltseva
Olga Maltseva Catalio Capital Management LP
14,718 $126,280 $275,594.55 $149,314.55 118.24%
Matthew Richmond
Matthew Richmond Richmond Investment Services, LLC
79,731 $1.99M $1.56M -$435,331.26 -21.84%
BGI
B Group Inc. B Group Inc.
610,169 $15.25M $11.6M -$3.66M -23.98%